Company news
Schrodinger, Inc. news in 2020
Schrodinger, Inc.'s news releases, calls and decks from 2020, newest first.
Schrödinger Presents Data from Its MALT1 Inhibitor Program at the American Society of Hematology (ASH) 2020 Annual Meeting
December 6, 2020
Schrödinger Announces a Multi-Target Drug Discovery, Development, and Commercialization Collaboration with Bristol Myers Squibb
November 22, 2020
Schrödinger, Inc. Reports Third Quarter 2020 Financial Results and Business Update
November 11, 2020
Schrödinger to Present at Upcoming Investor Conferences
November 9, 2020
Schrödinger to Present Data from Its MALT1 Inhibitor Program at the American Society of Hematology (ASH) 2020 Annual Meeting
November 4, 2020
Schrödinger to Host Third Quarter 2020 Financial Results Conference Call and Webcast
November 4, 2020
Schrödinger to Present at the Morgan Stanley 18th Annual Global Healthcare Conference
September 7, 2020
Schrödinger Announces Closing of Public Offering
August 16, 2020
Schrödinger Announces Pricing of Public Offering
August 11, 2020
Schrödinger, Inc. Reports Second Quarter 2020 Financial Results and Business Updates
August 9, 2020
Schrödinger Announces Proposed Public Offering of Common Stock
August 9, 2020
Schrödinger to Host Second Quarter 2020 Financial Results Conference Call and Webcast
August 2, 2020
Schrödinger and Viva Biotech Announce Strategic Collaboration to Generate and Interrogate Structures for Unsolved Targets
July 27, 2020
Calls in 2020
Decks in 2020
- Investor Presentation (June 2020)
Investor deck · 38 slides · Jun 12, 2020